SMS Pharmaceuticals Reports Mixed Financial Results with Strong Profitability Metrics in December 2024

Feb 12 2025 05:25 PM IST
share
Share Via
SMS Pharmaceuticals announced its financial results for the quarter ending December 2024, highlighting a strong operating profit to interest ratio and significant growth in profit after tax. However, the company also reported a decline in net sales, indicating a mixed financial performance amid evolving market conditions.
SMS Pharmaceuticals has recently reported its financial results for the quarter ending December 2024, with the announcement made on February 12, 2025. The company has experienced notable developments in its financial metrics, reflecting a mix of positive and challenging trends.

On the positive side, SMS Pharmaceuticals achieved its highest operating profit to interest ratio in the last five quarters, recorded at 7.91 times, indicating an enhanced capacity to manage interest obligations. Additionally, the profit after tax (PAT) reached Rs 18.24 crore, marking a significant growth of 23.0% compared to the average PAT of the previous four quarters. This quarter also saw the highest earnings per share (EPS) at Rs 2.15, suggesting improved profitability for shareholders. Furthermore, the debt-equity ratio has reached its lowest point at 0.51 times, reflecting a reduction in borrowing relative to equity capital.

Conversely, the company faced a decline in net sales, which totaled Rs 173.35 crore, down by 9.8% from the average of the previous four quarters. While non-operating income peaked at Rs 2.13 crore, there are concerns regarding the sustainability of this income source.

Overall, SMS Pharmaceuticals has undergone an adjustment in its evaluation, reflecting the complexities of its financial landscape.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News